Skip to main content

Advertisement

Table 2 Adverse sequelae after 3-day 3-AP then cisplatin (n = 6)

From: Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study

Adverse Event Category 0 1 2 3 4 5
Anemia 1 1 4 0 0 0
Leukopenia 1 2 2 1 0 0
Neutropenia 1 1 2 1 1 0
Thrombocytopenia 3 1 2 0 0 0
Allergy/Immunology 5 0 1 0 0 0
Constitutional 2 3 1 0 0 0
Dermatologic 3 1 2 0 0 0
Nausea 3 1 2 0 0 0
Vomiting 3 0 2 1 0 0
Gastrointestinal 3 2 0 1 0 0
Metabolic 3 1 2 0 0 0
Neurosensory 4 2 0 0 0 0
Other Neurological 4 1 1 0 0 0
Pain 5 0 0 1 0 0
Pulmonary 4 0 0 2 0 0